in Health care
Pay AstraZeneca royalties on total sales of ovarian cancer drug Zejula: UK Court orders GSK’s Tesaro
UK: A UK court on Wednesday ordered GSK’s Tesaro to pay rival AstraZeneca royalties on total sales of ovarian cancer drug Zejula, in a win for the Anglo-Swedish drugmaker. Tesaro had argued the royalty was payable only on sales that are for uses claimed or covered by the licensed patents, after AstraZeneca filed a UK […] More
